DNA methylation (5-methylcytosine,
5mC) is the most prevalent epigenetic
modification that is predominantly found in CG dinucleotides in mammalian
genomes. In-depth investigation of the functions of 5mC heavily relies
on the quantitative measurement of 5mC at single-base resolution in
genomes. Here, we proposed a methyltransferase-directed labeling with
APOBEC3A (A3A) deamination sequencing (MLAD-seq) method for the single-base
resolution and quantitative detection of 5mC in DNA. In MLAD-seq,
a mutant of DNA methyltransferase, M.MpeI-N374K, is utilized to selectively
transfer a carboxymethyl group to the 5 position of cytosine in the
CG dinucleotide to form 5-carboxymethylcytosine (5camC) using carboxy-S-adenosyl-l-methionine (caSAM) as the cofactor.
After A3A treatment, 5camC is resistant to the deamination and base
pairs with guanine. Thus, the cytosines in CG sites are read as C
in sequencing. On the contrary, the methyl group in 5mC inhibits its
carboxymethylcytosine by M.MpeI-N374K and therefore is readily deaminated
by A3A to produce thymine that pairs with adenine and is read as T
in sequencing. The differential readouts from C and 5mC in the MLAD-seq
enable the single-base resolution mapping of 5mC in CG sites in DNA.
With the developed MLAD-seq method, we observed the hypermethylation
in the promoter region of retinoic acid receptor β (RARB) gene from human nonsmall cell lung tumor tissue. Compared
to harsh reaction conditions in bisulfite sequencing that could lead
to significant degradation of DNA, the whole procedure of MLAD-seq
is carried out under mild conditions, which will avoid DNA damage.
Thus, MLAD-seq is more suitable in the scenario where only limited
input DNA is available. Taken together, the MLAD-seq offers a valuable
tool for bisulfite-free, single-base resolution and quantitative detection
of 5mC in limited DNA.